sluit venster

Log in

Gebruikersnaam Wachtwoord Gebruikersnaam en/of wachtwoord vergeten? Gebruikersnaam en wachtwoord aanvragen

Zoek in de HOVON website

Studies (all)


Study name Status Echelon level Stage Age Updated Included patients Active sites
HOVON 126 MM Closed Limited site selection 1st line 12-12-2016 143 40
HOVON 115 Double UCBT Closed Level A - 03-08-2015 70 6
HOVON-associated CMV pp65 specific T-cells Open n/a - 0 - 75 18-10-2012 n/a n/a
HOVON 34 MDS / EORTC 06961 Closed n/a 1st line 10 - 60 13-05-2008 n/a n/a
HOVON 29 AML / SAKK 30/95 Closed n/a 1st line 15 - 60 28-05-2008 n/a n/a
HOVON 27 NHL 94 Closed n/a 1st line 15 - 65 22-04-2010 n/a n/a
HOVON 26 NHL Closed n/a 1st line 15 - 65 28-05-2008 486 72
HOVON 32 MDS / ELDERLY AML Closed n/a 1st line 15 - 75 14-05-2008 n/a n/a
HOVON 37 ALL Closed n/a 1st line 16 - 59 20-07-2011 243 12
HOVON 18 ALL Closed n/a 1st line 16 - 60 13-05-2008 193 19
HOVON 38 CML Closed n/a 1st line 16 - 65 14-05-2008 102 22
HOVON 59 AML / SAKK / OSHO Closed n/a 1st line 16 - 75 23-05-2008 22 5
HOVON 70 ALL Closed n/a 1st line 18 - 39 20-04-2012 54 20
HOVON 72 AML Closed n/a 2nd line 18 - 60 23-05-2008 2 1
HOVON 66 AML Closed n/a 1st line 18 - 60 27-05-2008 n/a n/a
HOVON 42 A AML / SAKK Closed n/a 1st line 18 - 60 19-07-2011 514 24
HOVON 42 AML / SAKK Closed n/a 1st line 18 - 60 14-05-2008 1002 4
HOVON 90 T-NHL (ACT-1) Closed n/a 1st line 18 - 60 years 28-04-2014 n/a n/a
HOVON 133 MCL (TRIANGLE) Planned Level D - 18 - 65 25-04-2017 n/a n/a
HOVON 132 AML / SAKK Open Limited site selection 1st line 18 - 65 31-01-2017 858 52
HOVON 102 AML Closed Limited site selection 1st line 18 - 65 05-11-2013 862 45
HOVON 92 AML / SAKK Closed Limited site selection 1st line 18 - 65 20-10-2014 n/a n/a
HOVON 80 NHL Closed n/a 2nd line 18 - 65 19-09-2014 36 12
HOVON 78 CML Closed n/a 1st line 18 - 65 03-05-2010 110 30
HOVON 75 MCL Closed n/a 1st line 18 - 65 17-12-2012 133 16
HOVON 69 T-NHL Closed n/a 1st line 18 - 65 01-07-2008 20 19
HOVON 65 MM / GMMG HD4 Closed n/a 1st line 18 - 65 01-09-2011 828 75
HOVON 63 NHL Closed n/a 1st line 18 - 65 23-05-2008 40 31
HOVON 54 MM Closed n/a 1st line 18 - 65 26-07-2010 87 6
HOVON 51 CML Closed n/a 1st line 18 - 65 03-03-2014 164 16
HOVON 50 MM Closed n/a 1st line 18 - 65 23-08-2016 555 47
HOVON 45 MCL Closed n/a 1st line 18 - 65 16-05-2008 87 17
HOVON 44 NHL Closed n/a 2nd line 18 - 65 31-12-2013 232 24
HOVON 40 NHL Closed n/a 1st line 18 - 65 04-08-2008 93 21
HOVON 138 APL (APOLLO) Planned Limited site selection 1st line 18 - 65 years 02-05-2017 n/a n/a
HOVON 76 MM Closed n/a 1st line 18 - 66 27-11-2012 35 8
HOVON 35 NHL / EORTC 20963 Closed n/a 1st line 18 - 66 03-06-2008 n/a n/a
HOVON 146 B-ALL Planned Level A, Level B 1st line 18 - 70 24-05-2017 n/a n/a
HOVON 116 AML Open Level A 1st line 18 - 70 22-03-2017 131 7
HOVON 105 PCNSL / ALLG NHL24 Closed Level C-HIC 1st line 18 - 70 09-03-2017 200 28
HOVON 100 ALL / EORTC Closed Level C-SCT 3rd line 18 - 70 02-03-2017 373 30
HOVON 96 GVHD Open n/a 1st line 18 - 70 03-07-2015 448 7
HOVON 88 CLL Closed n/a 2nd line 18 - 70 26-09-2016 46 18
HOVON 74 ALL Closed n/a 2nd line 18 - 70 20-05-2009 2 8
HOVON 134 MF Planned Level A - 18 - 70 y 19-01-2017 n/a n/a
HOVON 79 APL / PETHEMA LPA 2005 Closed Level B 1st line 18 - 75 03-12-2015 90 11
HOVON 68 CLL Closed n/a 1st line 18 - 75 19-01-2015 274 71
HOVON 52 AML Closed n/a 1st line 18 - 75 31-12-2013 n/a n/a
HOVON 84 NHL Closed n/a 1st line 18 - 80 05-03-2013 585 68
HOVON 58 ET Closed n/a 1st line 18 - 80 09-11-2011 7 9
HOVON 107 MOBILIZATION Closed Level A - 18-60 21-02-2017 38 4
HOVON 131 MM / IFM 2015-01 Open n/a 1st line 18-65 24-01-2017 n/a n/a
HOVON 108 MM Closed Level A 2nd line 18-65 30-09-2013 30 7
HOVON 106 DOUBLE UCBT Closed n/a - 18-65 25-07-2016 41 5
HOVON 95 MM Closed Level D 1st line 18-65 27-03-2017 n/a 191
HOVON 104 AL AMYLOIDOSIS Closed n/a 1st line 18-70 22-03-2017 57 18
HOVON 144 NHL Planned Level D 2nd line 18-70 en 71-85 03-04-2017 n/a n/a
HOVON 127 BL Open Level C-HIC 1st line 18-75 02-03-2017 16 17
HOVON 71 ALL Closed n/a 1st line 40 - 70 20-04-2012 60 21
HOVON 53 AML / OSHO Closed n/a 1st line 50 - 75 18-10-2010 59 10
HOVON 91 T-NHL (ACT-2) Closed n/a 1st line 61-80 13-05-2014 n/a n/a
HOVON 109 CLL Closed Limited site selection 1st line 65 years – 80 years, inclusive; 18 - 64 years, inclusive, with CIRS ≥7 14-02-2017 63 34
HOVON 41 AL Amyloidosis Closed n/a 1st line < 66 28-05-2008 70 13
HOVON 24 MM / OG 96-020 Closed n/a 1st line < 66 13-05-2008 n/a n/a
HOVON-associated MM and haplo Open n/a 3rd line < 66 yrs 23-05-2016 n/a n/a
HOVON 143 MM Planned Level D 1st line > 18 19-10-2016 n/a n/a
HOVON 64 ITP Closed n/a 1st line > 18 07-05-2010 151 35
HOVON 60 MDS / SAKK 33/99 Closed n/a 1st line > 18 23-05-2008 6 3
HOVON 39 NHL / EORTC 20981 Closed n/a 2nd line > 18 22-05-2008 77 32
HOVON 30 AML Closed n/a 1st line > 18 13-05-2008 80 19
HOVON 20 CML Closed n/a 1st line > 18 13-05-2008 n/a n/a
HOVON 900 DLBCL screening Open 1st line > 18 year 26-09-2016 535 62
HOVON 81 AML Closed n/a 1st line > 60 08-10-2012 n/a n/a
HOVON 77 NHL Closed n/a 1st line > 60 10-06-2010 19 24
HOVON 43 AML Closed n/a 1st line > 60 15-01-2010 n/a n/a
HOVON 36 MM Closed n/a 1st line > 64 13-05-2008 69 49
HOVON 49 MM Closed n/a 1st line > 65 23-08-2016 344 64
HOVON 47 NHL Closed n/a 1st line > 65 16-05-2008 13 39
HOVON 25 NHL / OG 95-004 Closed n/a 1st line > 65 13-05-2008 n/a n/a
HOVON 120 NHL (ZEST) Closed n/a 2nd line > = 60 21-07-2014 n/a n/a
HOVON Pomalidomide project Open n/a 3rd line >18 17-11-2015 n/a n/a
HOVON-associated Innate allo-SCT Open n/a - >18 10-03-2016 n/a n/a
HOVON 136 NHL Planned Level B 2nd line >18 years 25-04-2017 n/a n/a
HOVON 129 PCL Open Level A 2nd line >18 yrs 27-02-2017 n/a 7
HOVON 114 MM Open Limited site selection 2nd line >18 yrs 27-02-2017 n/a 29
HOVON-associated Acerta CL-007 Open n/a - >65 OR >18 - 65 09-11-2015 n/a n/a
HOVON-associated Murano study Closed n/a 2nd line >= 18 31-08-2015 n/a n/a
HOVON 101 CLL/OMB112517 Closed n/a 2nd line >= 18 24-09-2014 n/a 19
HOVON 82 Sanquin Closed n/a 1st line >= 18 10-06-2009 295 8
HOVON 73 NHL / PRIMA Closed n/a 1st line >= 18 27-10-2014 18 14
HOVON 57 MM Closed n/a 1st line >= 18 22-05-2008 24 10
HOVON 48 NHL / NHLFIT Closed n/a 2nd line >= 18 09-04-2009 n/a n/a
HOVON-associated MEDI4736-NHL-001 Open n/a 2nd line >= 18 11-01-2017 n/a n/a
HOVON 110 FL Open n/a 2nd line >= 18 years 20-02-2017 54 48
HOVON-associated PLMA25 NK-cell study Closed n/a - >= 55 29-09-2015 n/a n/a
HOVON 119 MCL Open Level D 1st line >= 60 27-01-2017 n/a 24
HOVON 97 AML Closed Level C-HIC 1st line >= 60 20-04-2017 117 25
HOVON 67 AML / SAKK Closed n/a 1st line >= 60 23-05-2008 6 9
HOVON 93 AML / EBMT Closed Level B 1st line >= 60 <= 75 19-10-2016 n/a 6
HOVON 61 NHL Closed n/a 1st line >= 65 23-05-2008 n/a 7
HOVON 46 NHL Closed n/a 1st line >= 65 31-12-2013 265 73
HOVON 137 NHL On hold Level D - >= 75 27-12-2016 n/a n/a
HOVON 123 MM Closed Level D 1st line >= 75 23-05-2017 240 58
HOVON-associated Transplant BRaVE Open n/a - >=18 09-11-2015 n/a n/a
HOVON-associated SADAL trial (Protocol KCP-330-009) Open Level A 2nd line >=18 12-04-2017 n/a n/a
HOVON-associated GO27878 study (Cavalli study) Closed n/a - >=18 09-02-2017 n/a n/a
HOVON-associated CC-122 NHL-001 Open n/a 2nd line >=18 21-04-2016 n/a n/a
HOVON-associated CARINA (Protocol 54767414LYM2001) Closed Limited site selection 3rd line >=18 07-12-2016 n/a n/a
HOVON-associated Anti-CD20 cGVHD study Closed n/a - >=18 09-12-2015 n/a n/a
HOVON-associated Acerta CL-006 Open n/a 2nd line >=18 09-11-2015 n/a n/a
HOVON-associated ACE WM-001 Closed n/a - >=18 24-12-2015 n/a n/a
HOVON-associated ACE LY-004 Closed n/a - >=18 24-12-2015 n/a n/a
HOVON 141 CLL Planned Level D 2nd line >=18 04-04-2017 n/a n/a
HOVON 140 CLL Open Level D 1st line >=18 03-05-2017 n/a 2
HOVON 139 CLL (GIVE) Open Level D 1st line >=18 12-04-2017 21 20
HOVON 98 / OMB110928 Closed n/a 2nd line >=18 10-04-2014 n/a n/a
HOVON 89 MDS Closed Level D 1st line >=18 06-01-2017 184 54
HOVON 86 MM Closed Level C-HIC & C-SCT 2nd line >=18 11-03-2015 81 25
HOVON 85 NHL Closed n/a 2nd line >=18 12-04-2012 61 27
HOVON-associated MK-3475-087 Closed n/a 2nd line >=18 02-05-2016 n/a n/a
HOVON-associated GO29365 Closed Limited site selection 1st line >=18 14-10-2016 n/a n/a
HOVON 124 WM Open Limited site selection 2nd line >=18 y 16-01-2017 26 21
HOVON 117 ALL On hold n/a 1st line >=55 05-08-2016 n/a 1
HOVON 55 MCL Closed n/a 1st line >=65 or 60-65 (see inclusion criteria) 31-10-2016 95 30
HOVON 135 AML / SAKK Open Limited site selection 1st line >=66 21-03-2017 52 25
HOVON 103 AML Open Level C-HIC 1st line >=66 24-05-2017 574 3
HOVON 113 MSC Open Level A, Level B 2nd line Any age 19-11-2015 16 5
HOVON 112 MSC Open Level A 1st line Any age 15-06-2015 39 2
HOVON 130 NHL Open Level D 1st line ≥ 18 09-03-2017 57 23
HOVON 121 CLLM1/GCLLSG Closed Level D - ≥ 18 25-07-2016 n/a 4
HOVON 142 CML -SUSTRENIM-CML1415 Planned Level A, Level B, Level C-HIC & C-SCT 3rd line ≥18 24-05-2017 n/a n/a
HOVON 87 MM Closed Level D 1st line prev. untreated > 65 or <=65 when inelig. for HDT & PCST 06-01-2017 643 101